The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of ipilimumab (IPI) with biochemotherapy (BCT) for chemonaïve patients with metastatic melanoma (MM).
 
Rodabe Navroze Amaria
Research Funding - Novartis (Inst)
 
Roland L. Bassett
No Relationships to Disclose
 
Lauren Simpson
No Relationships to Disclose
 
Frances Delaney
No Relationships to Disclose
 
Patrick Hwu
Consulting or Advisory Role - Lion Biotechnologies
Research Funding - Bristol-Myers Squibb; Genentech
 
Kevin Kim
Honoraria - Genentech/Roche; GlaxoSmithKline; Novartis
Consulting or Advisory Role - Genentech/Roche; GlaxoSmithKline; Novartis
Research Funding - AstraZeneca (Inst); Eisai (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
 
Wen-Jen Hwu
No Relationships to Disclose
 
Sapna Pradyuman Patel
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline
Speakers' Bureau - Merck; Prometheus
Research Funding - Bristol-Myers Squibb; Deciphera; GlaxoSmithKline; Novartis; Prometheus; Reata Pharmaceuticals
 
Isabella Claudia Glitza
No Relationships to Disclose
 
Michael A. Davies
Consulting or Advisory Role - Genentech/Roche; GlaxoSmithKline; Novartis; Sanofi
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Myriad Genetics (Inst); Oncothyreon (Inst); Sanofi (Inst)
 
Scott Eric Woodman
No Relationships to Disclose
 
Cassian Yee
No Relationships to Disclose
 
Agop Y. Bedikian
No Relationships to Disclose